Literature DB >> 32428543

A Nitric Oxide-Releasing Topical Medication as a Potential Treatment Option for Atopic Dermatitis through Antimicrobial and Anti-Inflammatory Activity.

Emma Guttman-Yassky1, Richard L Gallo2, Ana B Pavel1, Teruaki Nakatsuji2, Randall Li1, Ning Zhang1, Elizabeth Messersmith3, Tomoko Maeda-Chubachi4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32428543     DOI： 10.1016/j.jid.2020.04.013

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  4 in total

Review 1.  Regulatory Role of Nitric Oxide in Cutaneous Inflammation.

Authors:  Mao-Qiang Man; Joan S Wakefield; Theodora M Mauro; Peter M Elias
Journal:  Inflammation       Date:  2022-01-30       Impact factor: 4.092

Review 2.  Recent advances on endogenous gasotransmitters in inflammatory dermatological disorders.

Authors:  Lian Wang; Xin Xie; Bowen Ke; Wei Huang; Xian Jiang; Gu He
Journal:  J Adv Res       Date:  2021-09-01       Impact factor: 12.822

Review 3.  Steroid Phobia: Is There a Basis? A Review of Topical Steroid Safety, Addiction and Withdrawal.

Authors:  Sean Yilong Tan; Nisha Suyien Chandran; Ellie Ci-En Choi
Journal:  Clin Drug Investig       Date:  2021-08-18       Impact factor: 2.859

4.  SB206, a Nitric Oxide-Releasing Topical Medication, Induces the Beginning of the End Sign and Molluscum Clearance.

Authors:  Tomoko Maeda-Chubachi; David Hebert; Elizabeth Messersmith; Elaine C Siegfried
Journal:  JID Innov       Date:  2021-05-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.